Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cerenion

Cerenion
2017 FOUNDED
PRIVATE STATUS
Seed LATEST DEAL TYPE
$618K LATEST DEAL AMOUNT
4 INVESTORS
Description

Developer of a technology for the measurement of brain function for diagnostic and therapeutic purposes in medicine. The company's technology uses machine learning algorithms and artificial intelligence to offer a method for measuring the brain function of intensive care patients, enabling doctors to improve both the quality and the cost of intensive care.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Primary Office
  • Elektroniikkatie 3
  • 90590 Oulu
  • Finland

+358 040 0000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cerenion’s full profile, request a free trial.

Cerenion Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 05-Feb-2018 $618K 00000 Completed Clinical Trials - General
2. Grant 18-Oct-2017 000.00 Completed Clinical Trials - General
1. Accelerator/Incubator 01-Jul-2017 Completed Clinical Trials - General
To view this company’s complete deal history including valuation and funding, request access »

Cerenion Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Butterfly Ventures Venture Capital Minority 000 0000 000000 0
Icebreaker VC Venture Capital Minority 000 0000 000000 0
Tekes Not-For-Profit Venture Capital 000 0000 000000 0
Life Science Accelerator Accelerator/Incubator 000 0000 000000 0

Cerenion Executive Team (4)

Name Title Board
Seat
Contact
Info
Timo Koskela Ph.D Chief Executive Officer & Co-Founder
Ilkka Juuso Chief Operations Officer & Co-Founder
Eero Väyrynen Ph.D Chief Technology Officer & Co-Founder
Jukka Kortelainen MD Chief Medical Officer & Co-Founder